Matinas BioPharma  Inc. logo

Matinas BioPharma Inc.

MTNB | AMEX
Chart Builder DCF Calculator
$1.51
-$0.39 (-20.53%)
At close: Oct 30, 2026, 3:59 PM ET
$1.19
-$0.32 (-21.19%)
Pre-market: Nov 2, 2026, 6:02 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-10.35M -24.25M -22.94M -21M -23.28M -22.45M
Depreciation & Amortization
452K 972K 941K 898K 781K 774.59K
Stock-Based Compensation
1.02M 3.2M 4.95M 5.23M 4.29M 4.56M
Other Working Capital
-1.73M 288K 1.77M -4.47M 947K -179.32K
Other Non-Cash Items
3.37M 4.41M 108K 504K 1.45M 239.83K
Deferred Income Tax
n/a -84K n/a n/a n/a 8.49K
Change in Working Capital
-1.51M -131K 1.67M -4.79M 1.54M -508.69K
Operating Cash Flow
-7.01M -15.89M -15.28M -19.16M -15.22M -17.37M
Capital Expenditures
n/a n/a -218K -892K -260K -5.75K
Cash Acquisitions
n/a n/a n/a n/a n/a 8.49M
Purchase of Investments
n/a -8.44M n/a -9.48M -23.2M -72.11M
Sales Maturities Of Investments
n/a 17.65M 13.46M 15.25M 40.23M 31.45M
Other Investing Acitivies
335K n/a n/a n/a n/a -8.49M
Investing Cash Flow
335K 9.21M 13.24M 4.88M 16.77M -40.67M
Debt Repayment
-9K -5K -7K -20K -30K -54.67K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a -682.8M
Other Financial Acitivies
-29K n/a n/a n/a 1.42M 684.2M
Financial Cash Flow
3.39M 9.17M -7K 79K 6.97M 48.05M
Net Cash Flow
-3.29M 2.5M -2.04M -14.2M 8.51M -9.99M
Free Cash Flow
-7.01M -15.89M -15.5M -20.05M -15.48M -17.37M
Adj. Free Cash Flow
-8.03M -19.08M -20.44M -25.28M -19.78M -21.94M
Maintenance CapEx
n/a n/a -218K n/a -260K n/a
Growth CapEx
n/a n/a n/a -892K n/a -5.75K
Owner Earnings
-7.01M -15.89M -15.5M -19.16M -15.48M -17.37M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.